MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-11-0061527
Grandeur Pharma Private Limited
Grandeur Pharma Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹32.83 Cr
▲ 7% YoY
Net profit · FY 2025
₹71.72 Lakh
Net margin 2.2%
EBITDA · FY 2025
₹1.34 Cr
EBITDA margin 4.1%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹75 Lakh
Issued & subscribed
Open charges
₹3.51 Cr
Secured borrowings
Company age
13 yrs
Est. 2013
Directors on board
2
As per MCA filings
About Grandeur Pharma Private Limited
Data last updated:
Grandeur Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 March 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2013PTC249057. Its GSTIN is 07AAFCG0941G1ZV (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹75 Lakh. It is led by directors Dhairya Ramchandani and Kushagra Ramchandani.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 47/1 Lower Ground Floor East Patel Nagar, New Delhi, Delhi, India – 110060.
As per the financials filed for FY 2025, the company reported a revenue of ₹32.83 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹71.72 Lakh (net margin 2.2%) and EBITDA of ₹1.34 Cr (EBITDA margin 4.1%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 8% over five years.
As per MCA filings, the company has open charges of ₹3.51 Cr on record.
Grandeur Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0061527). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24239DL2013PTC249057
Registration Number 249057
Incorporation Date 05 March 2013
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-11-0061527
Recognitions & Rankings of Grandeur Pharma
Contact details
Grandeur Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address47/1 Lower Ground Floor East Patel Nagar, New Delhi, Delhi, India – 110060
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Grandeur Pharma Private Limited, buy the company report.
Comprehensive company report
Grandeur Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Grandeur Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Grandeur Pharma Private Limited, buy the company report.
Financials of Grandeur Pharma Private Limited
FY 2024 filings availableGrandeur Pharma Private Limited reported revenue of ₹32.83 Cr (up 7% YoY) for FY 2025.
Revenue · FY 2025
₹32.83 Cr ▲ 7%
Net profit · FY 2025
₹71.72 Lakh margin 2.2%
EBITDA · FY 2025
₹1.34 Cr margin 4.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▼ 1%
5 years · compounded
▲ 8%
EBITDA CAGR growth
1 year
▲ 36%
3 years · compounded
▲ 22%
5 years · compounded
▲ 21%
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 7% growth in the latest year. EBITDA rose 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.34 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹71.72 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.1% | ||||
| Net Profit Margin | 2.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Grandeur Pharma Private Limited, buy the company report.
Board of directors of Grandeur Pharma Private Limited
Grandeur Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dhairya Ramchandani | Director | 05 Mar 2013 | 13 Years 8 Months | Current |
| Kushagra Ramchandani Also directs: Mod Hike Private Limited, Madhav Nirman Private Limited | Director | 02 Nov 2016 | 10 Years 0 Months | Current |
Peer comparison
Grandeur Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Maxlife Health Enterprises Private Limited | ₹33.02 Cr (FY 2024) | 25.0% | Bangalore, Karnataka, India | |||
| Grandeur Pharma Private Limitedthis company | ₹32.83 Cr (FY 2025) | ₹71.72 Lakh | 2.2% | 7.0% | New Delhi, Delhi, India | |
| Vexxa Lifesciences Private Limited | ₹32.79 Cr (FY 2025) | 9.0% | Mumbai, Maharashtra, India | |||
| C P Thakkar and Company (Pharma) Limited | ₹32.76 Cr (FY 2025) | 11.0% | Mumbai, Maharashtra, India | |||
| Icarus Health Care Private Limited | ₹32.55 Cr (FY 2025) | -13.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Grandeur Pharma Private Limited, buy the company report.
Auditor
Grandeur Pharma Private Limited is audited by JAIN ANKIT AND CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JAIN ANKIT AND CO | FY 2023 | 020485C |
Shareholding
The shareholding of Grandeur Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Grandeur Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹3.51 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Jul 2020 | 100369362 | Others | ₹48 Lakh | Open | |
| 27 Apr 2020 | 100369361 | Others | ₹27.5 Lakh | Open | |
| 10 Oct 2017 | 100166230 | Others | ₹2.75 Cr | Open |
To see the full charge records of Grandeur Pharma Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Grandeur Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Grandeur Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Grandeur Pharma has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCG0941G1ZV | Delhi | Active | 01 Jul 2017 |
| 05AAFCG0941G1ZZ | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Grandeur Pharma Private Limited, buy the company report.
Recent activity
Grandeur Pharma Private Limited has 4 board changes on record since 2013: 2 appointments and 2 cessations. The latest: Duiti Ramchandani ceased to be Director on 23 Jul 2020.
AGM
Grandeur Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Grandeur Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Ceased
Duiti Ramchandani ceased to be Director.
Charges
A charge with Others amounted to Rs. 0.48 Cr with Charge ID 100369362 was registered on 06 Jul 2020.
Charges
A charge with Others amounted to Rs. 0.28 Cr with Charge ID 100369361 was registered on 27 Apr 2020.
Charges
A charge with Others of Rs. 2.75 Cr registered on 10 Oct 2017 with Charge ID 100166230 was modified on 02 Jan 2019.
Charges
A charge with Others amounted to Rs. 2.75 Cr with Charge ID 100166230 was registered on 10 Oct 2017.
Ceased
Kushagra Ramchandani ceased to be Additional Director.
Appointed
Kushagra Ramchandani was appointed as Director.
Appointed
Dhairya Ramchandani was appointed as Director.
Incorporation
05 Mar 2013
Grandeur Pharma Private Limited was registered on 05 Mar 2013 with Roc Delhi & aged 13 years 8 months as per MCA records.
Frequently asked questions
Grandeur Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 March 2013 (13+ years old) and is registered under CIN U24239DL2013PTC249057.
Grandeur Pharma has 2 current directors:
- Dhairya Ramchandani - Director
- Kushagra Ramchandani - Director
The latest financial statements of Grandeur Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Grandeur Pharma is 07AAFCG0941G1ZV, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 05AAFCG0941G1ZZ (Uttarakhand).
The CIN (Corporate Identification Number) of Grandeur Pharma is U24239DL2013PTC249057. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Grandeur Pharma was incorporated on 05 March 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Grandeur Pharma by revenue are Maxlife Health Enterprises Private Limited, Vexxa Lifesciences Private Limited, C P Thakkar and Company (Pharma) Limited, Icarus Health Care Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Duiti Ramchandani ceased to be Director on 23 Jul 2020. Kushagra Ramchandani ceased to be Additional Director on 30 Sep 2017. Kushagra Ramchandani was appointed as Director on 02 Nov 2016. Grandeur Pharma has 4 board changes on record in total.
Yes, Grandeur Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-DL-11-0061527).
The registered office of Grandeur Pharma is at 471 Lower Ground Floor East Patel Nagar, New Delhi, Delhi, India – 110060.
Grandeur Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages